Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesothelioma
Scientists have developed a drug to treat mesothelioma, a notoriously hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.
Thousands of people are diagnosed with the disease globally every year, which tends to develop in the lungs and is mainly caused by exposure to asbestos at work. It is aggressive and deadly, and has one of the world’s worst cancer survival rates.
About Author
More Stories
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Bizarre Australian mole even more unusual than first thought, new research reveals